Immunome (IMNM) Cash from Investing Activities (QoQ) (2020 - 2026)
Immunome (IMNM) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Immunome | 2.51 Bn | 1.93 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -200.48% |
| Dec 31, 2025 | -103.23% |
| Sep 30, 2025 | 293.05% |
| Jun 30, 2025 | -1,360.97% |
| Mar 31, 2025 | -47.85% |
| Dec 31, 2024 | -59.51% |
| Sep 30, 2024 | 129.50% |
| Jun 30, 2024 | -119.41% |
| Mar 31, 2024 | -24.10% |
| Dec 31, 2023 | -83,238.89% |
| Sep 30, 2023 | 89.41% |
| Jun 30, 2023 | -220.75% |
| Mar 31, 2023 | -47.22% |
| Jun 30, 2022 | -2,733.33% |
| Mar 31, 2022 | 57.14% |
| Dec 31, 2021 | 46.15% |
| Sep 30, 2021 | -225.00% |
| Jun 30, 2021 | 74.19% |
| Mar 31, 2021 | 32.61% |
| Dec 31, 2020 | 62.90% |